Latest Retirement News

Iron Road has completed 464 metres of RC drilling at its TAU-A nickel-copper-gold target, but laboratory assays are still pending. The quarterly update also brings a major shareholder transition, a CEO retirement and a $1.21 million cash balance into sharper focus.

Promisia Healthcare has maintained group care occupancy at 96%, above its 95% target, while completing the Chatswood acquisition and preparing to potentially accelerate full ownership of Golden View Village. FY27 underlying EBITDAF guidance of at least $8.0 million remains unchanged for the existing portfolio, with updated guidance due in November.

InteliCare Holdings Limited (ASX:ICR) used FY2026 to move from pilot projects into contracted deployment, led by an estimated $8.8 million five-year agreement with mecwacare. Revenue and customer receipts more than doubled, although the company remains loss-making and reliant on disciplined rollout execution and further funding.

Legend Mining is preparing to test its Pyrophyllite Hill gold prospect with a 50-hole aircore program after completing heritage surveys. The explorer ended September with $9.24 million in cash, although the reported 19.5-quarter funding estimate is based on a relatively modest quarter of spending.

Abacus Group has begun an external search for a new managing director after Steven Sewell indicated he intends to retire by 9 July 2027, or earlier if a successor is appointed. The planned transition follows the completion of Storage King’s internalisation and comes with Sewell remaining in the role during the handover.

Ryman Healthcare’s retirement village resales reached an eight-quarter high in the second quarter, while aged care occupancy climbed to 94%. The operating update also shows new-sales inventory continuing to decline as the company positions for stronger recurring earnings.

Redox enters FY27 from a position of record revenue, higher margins and a debt-free balance sheet, while its North American business passes $100 million in sales. The chemical distributor also reported 9% higher average selling prices in the first quarter, although volumes remained broadly flat and freight costs increased.

High-Tech Metals has installed a new leadership team and arranged an 11.9% share crossing as it shifts focus from exploration to production at its Western Australian gold projects. The strategy is backed by approximately A$9 million in cash, but still depends on studies, approvals and shareholder decisions.

Promisia Healthcare has completed its acquisition of Chatswood Retirement Village after receiving shareholder approval in August. The vendors were paid through the issue of 1 million ordinary shares and 1 million unquoted convertible notes, leaving key transaction terms to be assessed in future disclosures.

Chimeric Therapeutics remains suspended from ASX trading after failing to lodge its FY2026 financial statements, with the company reporting an approximate $7.7 million net asset deficiency and unresolved creditor negotiations. Potential recapitalisation interest has emerged, but no binding funding or settlement agreement has been reached.

Civmec delivered double-digit earnings growth in FY26, with its new defence arm helping lift the order book to A$1.4 billion. The stronger profit came alongside a sharp working-capital squeeze that left operating cash flow negative after investment in growth.

Cassius Mining reported a deeper FY2026 loss, negative net assets and a material uncertainty over its ability to continue as a going concern. The company is relying on further funding, a possible Ghana arbitration award and progress at its Soalara limestone project to support its next phase.